Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently-Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD).

Introduction: Smoking cessation is important for men and women diagnosed with cancer. Oncology clinicians should encourage all patients to quit and offer resources to help them do so, following the 5As framework (Ask, Advise, Assess, Assist, and Arrange follow-up).

Method: This study tests gender differences in self-reported receipt of the 5As by an oncology provider among 306 recently-diagnosed male and female cancer patients.

Multilevel factors influence the use of a cardiovascular disease assessment tool embedded in the electronic health record in oncology care.

Digital health tools are positive for delivering evidence-based care. However, few studies have applied rigorous frameworks to understand their use in community settings. This study aimed to identify implementation determinants of the Automated Heart-Health Assessment (AH-HA) tool within outpatient oncology settings as part of a hybrid effectiveness-implementation trial.

Dermatological Conditions of the Breast.

There are many dermatologic conditions that can involve the skin of the breast including malignancy, infections, and inflammatory conditions. These are summarized here including presentation and management options.

Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers.

Purpose: Optimal cancer care requires patient self-management and coordinated timing and sequence of interdependent care. These are challenging, especially in safety-net settings treating underserved populations. We evaluated the 4R Oncology model (4R) of patient-facing care planning for impact on self-management and delivery of interdependent care at safety-net and non-safety-net institutions.

Dense Breasts: What Do Our Patients Need to Be Told and Why?

More than 50 % of states have state-mandated density notification for patients with heterogeneously or extremely dense breasts. Increased breast density carries a risk of masking a cancer and delaying diagnosis. Supplemental imaging is optional and often recommended for certain patients.

Papillomas of the breast 15 mm or smaller: 4-year experience in a community-based dedicated breast imaging clinic.

Purpose: To determine the significance of small, often mammographically occult and asymptomatic papillomas of the breast 15 mm and smaller.

Methods: Four-year retrospective review of papillomas of the breast in a community-based dedicated breast imaging center, with a selected cohort of 179 papillomas 15 mm or smaller in 147 patients, all completing image-guided core biopsy followed by surgical excision.

Results: Of 179 papillomas 15 mm or smaller, 36 % were abnormal (24 % atypia; 12 % cancer).

Surgical site infection after breast surgery: impact of 2010 CDC reporting guidelines.

Background: Reported surgical site infection (SSI) rates after breast operations ranges 0.8-26 % in the literature. The aims of the present study were to characterize SSI after breast/axillary operations and determine the impact on the SSI rate of the 2010 Centers for Disease Control and Prevention (CDC) reporting guidelines that now specifically exclude cellulitis.

Microbiology of surgical site infections complicating breast surgery.

Background: Surgical site infection (SSI) rates complicating breast surgery have ranged from 1-26%, but limited data have been provided regarding pathogen identification and in vitro susceptibility results. The aim of this study was to evaluate the results of bacterial cultures of breast SSI sites and antibiotic susceptibility testing to determine the clinical utility of these findings.

Study Design: Medical records were reviewed for SSI in patients who had undergone breast/axillary surgical procedures between June 2003 and June 2006.

Complications associated with postoperative antibiotic prophylaxis after breast surgery.

Background: Evidence supports single-dose preoperative antibiotic (ABX) prophylaxis for breast surgery; however, limited data exist regarding the incidence and type of antibiotic complications postoperatively.

Methods: Breast/axillary surgeries between July 2004 and June 2006 were reviewed. Complications were analyzed by antibiotic group: preoperative prophylaxis, postoperative prophylaxis, and therapeutic intent.

Bacteriologic features of surgical site infections following breast surgery.

Background: Perioperative antibiotic prophylaxis to prevent surgical site infections (SSIs) after breast surgery is common practice. Breast SSIs were investigated to determine bacterial isolates, resistance patterns, and the appropriateness of cefazolin, the authors' institution's current regimen for perioperative antibiotic prophylaxis.

Methods: A retrospective review of 53 patients with culture-positive breast SSIs between June 1997 and August 2008 identified patient characteristics, bacterial isolates, and microbial resistance patterns.

Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients.

Background: A single preoperative prophylactic dose of an intravenous antibiotic with antistaphylococcal activity is standard of care for breast and axillary surgical procedures. Some surgeons also prescribe postoperative prophylaxis for all patients with drains to prevent infection despite its lack of proven efficacy.

Methods: A retrospective chart review of patients with breast and/or axillary surgical procedures between July 2004 and June 2006 were included.

Sclerotherapy for the treatment of postmastectomy seroma.

Background: Seroma is a common complication after mastectomy. We review our experience with sclerotherapy for postmastectomy seroma management.

Methods: Patients who underwent outpatient sclerotherapy for postmastectomy seroma were reviewed.